Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>

Common stock purchase or sale:
Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
2023-01-31 Purchase |
2023-01-31 10:14 am |
Compass Therapeutics Inc. | CMPX | Schuetz Thomas J. CHIEF EXECUTIVE OFFICER |
20,000 | $4.05 | $81,000 | 5,471,873 (Direct) |
View |
2023-01-24 Purchase |
2023-01-24 10:49 am |
Compass Therapeutics Inc. | CMPX | Schuetz Thomas J. CHIEF EXECUTIVE OFFICER |
20,000 | $4.19 | $83,800 | 5,451,873 (Direct) |
View |
2022-11-22 Sale |
2022-11-25 4:41 pm |
Compass Therapeutics Inc. | CMPX | Bisker-Leib Vered Chief Operating Officer |
24,500 | $4.233 | $103,708 | 1,060,414 (Direct) |
View |
2022-11-18 Sale |
2022-11-22 4:15 pm |
Compass Therapeutics Inc. | CMPX | Bisker-Leib Vered Chief Operating Officer |
22,261 | $4.3568 | $96,986 | 1,084,914 (Direct) |
View |
2022-11-08 Purchase |
2022-11-10 4:44 pm |
Compass Therapeutics Inc. | CMPX | ORBIMED ADVISORS LLC OrbiMed Capital GP V LLC OrbiMed Genesis GP LLC Director 10% Owner |
402,000 | $3.21 | $1,290,420 | 18,791,422 (Indirect) |
View |
2022-11-08 Purchase |
2022-11-10 4:38 pm |
Compass Therapeutics Inc. | CMPX | GORDON CARL L Director 10% Owner |
402,000 | $3.21 | $1,290,420 | 18,791,422 (Indirect) |
View |
2022-09-28 Purchase |
2022-09-28 4:45 pm |
Compass Therapeutics Inc. | CMPX | Schuetz Thomas J. CHIEF EXECUTIVE OFFICER |
10,000 | $2.32 | $23,200 | 5,431,873 (Direct) |
View |
2022-09-26 Purchase |
2022-09-27 09:47 am |
Compass Therapeutics Inc. | CMPX | Schuetz Thomas J. CHIEF EXECUTIVE OFFICER |
15,000 | $2.27 | $34,050 | 5,421,873 (Direct) |
View |
2022-09-07 Purchase |
2022-09-08 10:12 am |
Compass Therapeutics Inc. | CMPX | Schuetz Thomas J. CHIEF EXECUTIVE OFFICER |
15,000 | $3.03 | $45,450 | 5,406,873 (Direct) |
View |
2022-09-01 Purchase |
2022-09-01 2:37 pm |
Compass Therapeutics Inc. | CMPX | Schuetz Thomas J. CHIEF EXECUTIVE OFFICER |
15,000 | $2.83 | $42,450 | 5,391,873 (Direct) |
View |
2022-08-17 Purchase |
2022-08-17 4:06 pm |
Compass Therapeutics Inc. | CMPX | Schuetz Thomas J. CHIEF EXECUTIVE OFFICER |
15,000 | $3.05 | $45,750 | 5,376,873 (Direct) |
View |
2022-08-10 Purchase |
2022-08-10 10:51 am |
Compass Therapeutics Inc. | CMPX | Schuetz Thomas J. CHIEF EXECUTIVE OFFICER |
15,000 | $2.64 | $39,600 | 5,361,873 (Direct) |
View |
2022-08-01 Purchase |
2022-08-02 09:15 am |
Compass Therapeutics Inc. | CMPX | Schuetz Thomas J. CHIEF EXECUTIVE OFFICER |
15,000 | $2.58 | $38,700 | 5,346,873 (Direct) |
View |
2022-06-21 Purchase |
2022-06-21 1:41 pm |
Compass Therapeutics Inc. | CMPX | Schuetz Thomas J. CHIEF EXECUTIVE OFFICER |
20,000 | $2.8 | $56,000 | 5,331,873 (Direct) |
View |
2022-06-16 Purchase |
2022-06-17 4:46 pm |
Compass Therapeutics Inc. | CMPX | Schuetz Thomas J. CHIEF EXECUTIVE OFFICER |
20,000 | $2.34 | $46,800 | 5,311,873 (Direct) |
View |
2022-06-13 Purchase |
2022-06-13 3:59 pm |
Compass Therapeutics Inc. | CMPX | Schuetz Thomas J. CHIEF EXECUTIVE OFFICER |
30,000 | $2.29 | $68,700 | 5,291,873 (Direct) |
View |
2022-06-06 Purchase |
2022-06-07 11:50 am |
Compass Therapeutics Inc. | CMPX | Schuetz Thomas J. CHIEF EXECUTIVE OFFICER |
30,000 | $2.83 | $84,900 | 5,261,873 (Direct) |
View |
2022-06-01 Purchase |
2022-06-01 12:33 pm |
Compass Therapeutics Inc. | CMPX | Schuetz Thomas J. CHIEF EXECUTIVE OFFICER |
20,000 | $3.03 | $60,600 | 5,231,873 (Direct) |
View |
2022-05-26 Purchase |
2022-05-26 2:58 pm |
Compass Therapeutics Inc. | CMPX | Schuetz Thomas J. CHIEF EXECUTIVE OFFICER |
20,000 | $3.04 | $60,800 | 5,211,873 (Direct) |
View |
2022-05-23 Purchase |
2022-05-24 08:09 am |
Compass Therapeutics Inc. | CMPX | Schuetz Thomas J. CHIEF EXECUTIVE OFFICER |
18,355 | $2.72 | $49,926 | 5,191,873 (Direct) |
View |
2022-05-17 Purchase |
2022-05-17 3:17 pm |
Compass Therapeutics Inc. | CMPX | Schuetz Thomas J. CHIEF EXECUTIVE OFFICER |
20,215 | $2.47 | $49,931 | 5,173,518 (Direct) |
View |
2022-05-11 Purchase |
2022-05-13 5:48 pm |
Compass Therapeutics Inc. | CMPX | GORDON CARL L Director 10% Owner |
192,516 | $2.1841 | $420,482 | 18,389,422 (Indirect) |
View |
2022-05-11 Purchase |
2022-05-13 5:45 pm |
Compass Therapeutics Inc. | CMPX | ORBIMED ADVISORS LLC OrbiMed Capital GP V LLC OrbiMed Genesis GP LLC Director 10% Owner |
192,516 | $2.1841 | $420,482 | 18,389,422 (Indirect) |
View |
2022-05-06 Purchase |
2022-05-10 6:21 pm |
Compass Therapeutics Inc. | CMPX | ORBIMED ADVISORS LLC OrbiMed Capital GP V LLC OrbiMed Genesis GP LLC Director 10% Owner |
125,359 | $1.5735 | $197,252 | 18,196,906 (Indirect) |
View |
2022-05-06 Purchase |
2022-05-10 6:19 pm |
Compass Therapeutics Inc. | CMPX | GORDON CARL L Director 10% Owner |
125,359 | $1.5735 | $197,252 | 18,196,906 (Indirect) |
View |
2022-05-10 Purchase |
2022-05-10 2:15 pm |
Compass Therapeutics Inc. | CMPX | Schuetz Thomas J. CHIEF EXECUTIVE OFFICER |
27,836 | $1.8 | $50,105 | 5,153,303 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
2023-02-08 Option Award |
2023-02-09 4:31 pm |
N/A 2033-02-07 |
Compass Therapeutics Inc. | CMPX | Chiniara Ellen Director |
40,000 | $0 | 40,000 (Direct) |
View |
2023-02-08 Option Award |
2023-02-09 4:31 pm |
N/A 2033-02-07 |
Compass Therapeutics Inc. | CMPX | GRAY MARY ANN Director |
40,000 | $0 | 40,000 (Direct) |
View |
2023-02-08 Option Award |
2023-02-09 4:28 pm |
N/A 2033-02-07 |
Compass Therapeutics Inc. | CMPX | Ferneau Philip Director |
50,000 | $0 | 50,000 (Direct) |
View |
2023-02-08 Option Award |
2023-02-09 4:28 pm |
N/A 2033-02-07 |
Compass Therapeutics Inc. | CMPX | GORDON CARL L Director 10% Owner |
60,000 | $0 | 60,000 (Direct) |
View |
2023-02-08 Option Award |
2023-02-09 4:23 pm |
N/A 2033-02-07 |
Compass Therapeutics Inc. | CMPX | Schuetz Thomas J. CHIEF EXECUTIVE OFFICER |
1,200,000 | $0 | 6,671,873 (Direct) |
View |
2023-02-08 Option Award |
2023-02-09 3:03 pm |
N/A 2033-02-07 |
Compass Therapeutics Inc. | CMPX | Bisker-Leib Vered Chief Operating Officer |
1,000,000 | $0 | 2,084,914 (Direct) |
View |
2022-04-26 Option Award |
2022-04-28 1:52 pm |
N/A 2032-04-25 |
Compass Therapeutics Inc. | CMPX | GRAY MARY ANN Director |
45,000 | $0 | 45,000 (Direct) |
View |
Ownership |
2022-04-28 1:50 pm |
N/A N/A |
Compass Therapeutics Inc. | CMPX | GRAY MARY ANN Director |
0 | $0 | 0 (Direct) |
View |
2022-04-26 Option Award |
2022-04-28 1:29 pm |
N/A 2032-04-25 |
Compass Therapeutics Inc. | CMPX | Chiniara Ellen Director |
45,000 | $0 | 45,000 (Direct) |
View |
Ownership |
2022-04-28 1:28 pm |
N/A N/A |
Compass Therapeutics Inc. | CMPX | Chiniara Ellen Director |
0 | $0 | 0 (Direct) |
View |
2022-02-18 Option Award |
2022-02-23 5:45 pm |
N/A 2032-02-17 |
Compass Therapeutics Inc. | CMPX | Ferneau Philip Director |
30,000 | $0 | 30,000 (Direct) |
View |
2022-02-18 Option Award |
2022-02-23 5:45 pm |
N/A 2032-02-17 |
Compass Therapeutics Inc. | CMPX | GORDON CARL L Director 10% Owner |
30,000 | $0 | 30,000 (Direct) |
View |
2022-02-18 Option Award |
2022-02-23 5:45 pm |
N/A 2032-02-17 |
Compass Therapeutics Inc. | CMPX | Kaplan Brett Director |
30,000 | $0 | 30,000 (Direct) |
View |